Thoratec's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Thoratec Corporation ( THOR)

Q4 2011 Earnings Call

February 8, 2012 4:30 pm ET

Executives

Taylor Harris – Senior Director, Investor Relations & Business Development

Gerhard F. Burbach – President, Chief Executive Officer and Director

Roxanne Oulman – Interim Chief Financial Officer

Analysts

Danielle Antalffy – Leerink Swann

Matthew Taylor – Barclays Capital

Thomas Gunderson – Piper Jaffray

Lennox Ketner – Bank of America

David Roman – Goldman Sachs

Jayson Bedford – Raymond James

Steven Lichtman – Oppenheimer & Co.

Jason Mills – Canaccord Genuity

Spencer Nam – Thinkequity Llc

Christopher Pasquale – JPMorgan

Larry Biegelsen – Wells Fargo Securities, Llc

Timothy Philosophos – Rodman & Renshaw, LLC

Rajeev Jashnani – UBS

Presentation

Operator

Good day, and welcome to the Thoratec Corporation Fourth Quarter and Fiscal Year 2011 Earnings Results Conference Call. As a reminder, today's conference is being recorded. At this time, I'd like to turn the conference over to Mr. Taylor Harris, Senior Director, Investor Relations and Business Development. Please go ahead, sir.

Taylor Harris

Thanks, Kevin. Good afternoon, and thank you for joining us today. With me are Gary Burbach, President and Chief Executive Officer; and Roxanne Oulman, the company's Interim Chief Financial Officer. Gary will discuss highlights from the quarter and fiscal year 2011, and then turn to our key operational and strategic objectives for 2012. Roxanne will review the financial results for the quarter and provide an update on guidance for 2012. We will then open the call to your questions.

Before turning the call over to Gary, I want to remind you that, during the course of today's conference call and the question-and-answer session that follows, we may make projections or other forward-looking statements that are subject to the Safe Harbor provisions of the Securities laws regarding future events or the financial performance of the company.

If you liked this article you might like

Thor Industries Stock Drops Double Digits on Mixed Earnings

Oil, Yellen and World GDP Growth: How to Trade the Week Ahead

HeartWare Falters After Announcing Valtech Cardio Acquisition

Thoratec (THOR) Moving On Heavy Volume In The Pre-Market Hours

Thoratec Sale May Be Precursor of More Cardiac Industry M&A